 |
1-(2-chlorophenyl)-1-(S)-hydroxy-2-(S)-carbamoyloxy-propane |
|---|---|
| Trade Name | |
| Orphan Indication | Status epilepticus |
| USA Market Approval | USA |
| USA Designation Date | 2016-07-07 00:00:00 |
| Sponsor | Bio-Pharm Solutions Co., Ltd.;Advanced Institute of Convergence Technology, 6F, C Bldg;Yeongtong Suwon |
